Characterization of the p68/p58 heterodimer of human immunodeficiency virus type 2 reverse transcriptase

被引:18
|
作者
Fan, NS
Rank, KB
Poppe, SM
Tarpley, WG
Sharma, SK
机构
[1] UPJOHN CO,UPJOHN LABS,BIOCHEM,KALAMAZOO,MI 49001
[2] UPJOHN CO,UPJOHN LABS,CAN & INFECT DIS RES,KALAMAZOO,MI 49001
关键词
D O I
10.1021/bi9516440
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Recently we demonstrated that the p58 subunit of p68/p58 HIV-2 reverse transcriptase (RT) heterodimer, produced by processing of p68/p68 homodimer with recombinant HIV-2 protease, terminates at Met(484) [Fan, N., et al. (1995) J. Biol. Chem. 270, 13573-13579]. Here we describe purification and characterization of the p68/p58 heterodimer of recombinant HIV-2 RT. It exhibited both RT and RNase H activities, obeyed Michaelis-Menten kinetics, and was competitively inhibited by the DNA chain terminator ddTTP (K-i[app] = 305 +/- 20 nM). The HIV-2 RT-associated RNase H exhibited a marked preference for RNA hydrolysis from a HIV-1 gag-based heteropolymeric RNA/DNA hybrid in the presence of either Mg2+ or Mn2+, compared to the [H-3]poly(rA). poly(dT) or [H-3]poly(rG). poly(dC) homopolymeric substrates. Relative to HIV-1 RT, the RNase H activity of HIV-2 RT was only 5% toward the [H-3]poly(rA) poly(dT) in the presence of Mg2+. The size distribution of products generated from [H-3]poly(rA). poly(dT) by HIV-2 RT-associated RNase H was markedly distinct from that of HIV-1 RT in the presence of Mg2+ Or Mn2+. The p68/p58 HIV-2 RT heterodimer, produced by specific cleavage using HIV-2 protease, should be useful for inhibition and biophysical studies aimed at discovering and designing drugs directed toward HIV-2.
引用
收藏
页码:1911 / 1917
页数:7
相关论文
共 50 条
  • [41] Interaction between human immunodeficiency virus type I reverse transcriptase and integrase proteins
    Hehl, EA
    Joshi, P
    Kalpana, GV
    Prasad, VR
    JOURNAL OF VIROLOGY, 2004, 78 (10) : 5056 - 5067
  • [42] Metabolism of the human immunodeficiency virus type 1 reverse transcriptase inhibitor delavirdine in rats
    Chang, M
    Sood, VK
    Wilson, GJ
    Kloosterman, DA
    Sanders, PE
    Hauer, MJ
    Fagerness, PE
    DRUG METABOLISM AND DISPOSITION, 1997, 25 (02) : 228 - 242
  • [43] Effect of manuka honey on human immunodeficiency virus type 1 reverse transcriptase activity
    Obossou, Etienne Kochole
    Shikamoto, Yasuo
    Hoshino, Yuki
    Kohno, Hayato
    Ishibasi, Yukiko
    Kozasa, Tohru
    Taguchi, Maho
    Sakakibara, Iwao
    Tonooka, Keiko
    Shinozuka, Tatsuo
    Mori, Kazuya
    NATURAL PRODUCT RESEARCH, 2022, 36 (06) : 1552 - 1557
  • [44] Inhibition of Foamy Virus Reverse Transcriptase by Human Immunodeficiency Virus Type 1 RNase H Inhibitors
    Corona, Angela
    Schneider, Anna
    Schweimer, Kristian
    Roesch, Paul
    Woehrl, Birgitta M.
    Tramontano, Enzo
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2014, 58 (07) : 4086 - 4093
  • [45] Virtual screening, identification, and biochemical characterization of novel inhibitors of the reverse transcriptase of human immunodeficiency virus type-1
    Herschhorn, Alon
    Hizi, Amnon
    JOURNAL OF MEDICINAL CHEMISTRY, 2008, 51 (18) : 5702 - 5713
  • [46] 2 HIGHLY ANTIGENIC SITES IN THE HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 REVERSE-TRANSCRIPTASE
    BJORLING, E
    BOUCHER, CAB
    SAMUELSSON, A
    WOLFS, TFW
    UTTER, G
    NORRBY, E
    CHIODI, F
    JOURNAL OF CLINICAL MICROBIOLOGY, 1993, 31 (03) : 588 - 592
  • [47] HuR interacts with human immunodeficiency virus type 1 reverse transcriptase, and modulates reverse transcription in infected cells
    Julie Lemay
    Priscilla Maidou-Peindara
    Thomas Bader
    Eric Ennifar
    Jean-Christophe Rain
    Richard Benarous
    Lang Xia Liu
    Retrovirology, 5
  • [48] HuR interacts with human immunodeficiency virus type 1 reverse transcriptase, and modulates reverse transcription in infected cells
    Lemay, Julie
    Maidou-Peindara, Priscilla
    Bader, Thomas
    Ennifar, Eric
    Rain, Jean-Christophe
    Benarous, Richard
    Liu, Lang Xia
    RETROVIROLOGY, 2008, 5 (1)
  • [49] Inhibitors of human immunodeficiency virus type 1 reverse transcriptase target distinct phases of early reverse transcription
    Hooker, CW
    Lott, WB
    Harrich, D
    JOURNAL OF VIROLOGY, 2001, 75 (07) : 3095 - 3104
  • [50] Human immunodeficiency virus mutagenesis during antiviral therapy: Impact of drug-resistant reverse transcriptase and nucleoside and nonnucleoside reverse transcriptase inhibitors on human immunodeficiency virus type 1 mutation frequencies
    Chen, RX
    Yokoyama, M
    Sato, H
    Reilly, C
    Mansky, LA
    JOURNAL OF VIROLOGY, 2005, 79 (18) : 12045 - 12057